Mostafa Shahein, MD | |
3100 Sw 62nd Ave, Miami, FL 33155-3009 | |
(305) 666-6511 | |
Not Available |
Full Name | Mostafa Shahein |
---|---|
Gender | Male |
Speciality | Neurological Surgery |
Location | 3100 Sw 62nd Ave, Miami, Florida |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144853623 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | 30031 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mostafa Shahein, MD 5285 Tansas Ln, Hilliard, OH 43026-7247 Ph: (614) 641-9685 | Mostafa Shahein, MD 3100 Sw 62nd Ave, Miami, FL 33155-3009 Ph: (305) 666-6511 |
News Archive
Cell Therapeutics, Inc. (CTI) announced today that on December 24, 2009, CTI's Board of Directors (the "Board of Directors") approved and adopted a Shareholder Rights Plan (the "Rights Plan") in which one preferred stock purchase right will be distributed for each common share held as of the close of business on January 7, 2010. Initially, the rights are not exercisable, and are attached to and trade with, all of the shares of CTI's common stock outstanding as of, and issued subsequent to, the record date.
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced that it has closed on its previously announced licensing and stock purchase agreements with Teva Pharmaceutical Industries Limited, a top 20 pharmaceutical company, for the development of its novel anti-cancer compound, RX-3117. RX-3117 is a small molecule, new chemical entity (NCE), nucleoside compound that has an anti-metabolite mechanism of action, and has therapeutic potential in a broad range of cancers including colon, lung and pancreatic cancer.
In a joint study, researchers at the Johns Hopkins Bloomberg School of Public Health and Arizona State University found evidence suggesting that a class of antibiotics previously banned by the U.S. government for poultry production is still in use. Results of the study were published March 21 in Environmental Science & Technology.
Today, Rethink Breast Cancer (Rethink) applauds the Ontario government's decision to provide breast cancer patients with tumours less than or equal to 1 cm access to the revolutionary drug Herceptin under the new Evidence Building Program.
Polyps in the mucosa of the colon are a common finding during screening colonoscopies. Some sub-groups of polyps are classed as precursors of bowel cancer. Until now, it has not been possible to precisely estimate the risk of these polyps developing into bowel cancer.
› Verified 9 days ago
Dr. Michael Yung-shun Wang, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1095 Nw 14th Terrace, Miami, FL 33136 Phone: 305-243-6946 Fax: 305-243-3337 | |
Vitaly Siomin, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 8950 N Kendall Dr Ste 407w, Miami, FL 33176 Phone: 786-596-3876 | |
Richard Gershanik, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 8390 W Flagler St, Ste. 107, Miami, FL 33144 Phone: 305-551-8088 Fax: 305-551-7603 | |
Adib Adnan Abla, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1295 Nw 14th Terr, Miami, FL 33125 Phone: 305-243-6946 | |
Dr. Justin Matthew Sporrer, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 8950 N Kendall Dr, Suite 407w, Miami, FL 33176 Phone: 305-271-6159 Fax: 786-533-9989 | |
Kwame Gyamfi Buahin, MD PHD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1190 Nw 95th St, Ste 403, Miami, FL 33150 Phone: 305-693-8804 Fax: 305-693-8807 | |
Brian Park, Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1095 Nw 14th Ter Fl 2, Miami, FL 33136 Phone: 305-243-6946 Fax: 305-243-3337 |